Key facts
- Notable investors include InnoPinnacle.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Jiyan Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Jiyan Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jiyan Biotech
Developer of in vitro biological models intended for preclinical drug evaluation and disease mechanism research. The company offers organoid construction kits derived from human and animal tissues, organ-on-a-chip customization services, multi-parameter pharmacodynamic testing, and inflammation and metabolic disease modeling tools, serving pharmaceutical companies, clinical researchers, and academic institutions to access scalable, reproducible, and physiologically relevant systems for drug screening, target validation, and personalized medicine development.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2019
- Employees
- 2
- Website
- jiyanbio.com/
- Ownership
- Privately Held (backing)
Jiyan Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jiyan Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jiyan Biotech in its N-PORT filings yet. We sweep new filings monthly.